ARBUTUS BIOPHARMA CORP (ABUS)

CA03879J1003 - Common Stock

2.58  -0.02 (-0.77%)

After market: 2.6 +0.02 (+0.78%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to ABUS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.49. This target is 73.95% above the current price.
ABUS was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ABUS.
In the previous month the buy percentage consensus was at a similar level.
ABUS was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 2.584.044.084.495.25 - 56.59% 58.14% 73.95% 103.49%
Up and Down Grades
Date Firm Action Rating
2024-03-01 Chardan Capital Reiterate Buy -> Buy
2024-03-01 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-04 Chardan Capital Reiterate Buy -> Buy
2023-08-04 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-11 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-06 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-06-22 Chardan Capital Reiterate Buy -> Buy
2023-06-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-05 HC Wainwright & Co. Reiterate Buy
2023-04-28 HC Wainwright & Co. Reiterate Buy
2023-04-05 HC Wainwright & Co. Reiterate Buy
2023-03-29 JMP Securities Reiterate Market Outperform
2023-03-20 HC Wainwright & Co. Reiterate Buy
2023-03-03 Chardan Capital Reiterate Buy
2023-03-03 HC Wainwright & Co. Maintains Buy
2022-11-10 HC Wainwright & Co. Maintains Buy
2022-06-28 JMP Securities Maintains Market Outperform
2022-03-04 Chardan Capital Maintains Buy
2022-02-02 Jefferies Upgrade Hold -> Buy
2021-11-08 JMP Securities Maintains Market Outperform